Christopher D Alafi
CIK 1299430 · last filed 2021-05-28
Christopher D Alafi is a corporate insider who has filed 87 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider sold $1.9M of ITCI on May 28, 2021. Across all open-market trades the lifetime net is +$39.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.42M
2
87
$39.60M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 850,548 | $131.87 | $112.16M | $32.97M | 55 | 2021-05-28 |
| STXS | Director | 1,313,441 | $1.84 | $2.42M | $6.64M | 32 | 2013-08-20 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Sell (S) | −47,325 | -$1.90M | EDGAR |
| 2021-05-25 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Sell (S) | −27,675 | -$1.12M | EDGAR |
| 2021-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +464 | $15.7K | EDGAR |
| 2021-01-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +495 | $15.7K | EDGAR |
| 2020-10-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +613 | $15.7K | EDGAR |
| 2020-09-14 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +49,500 | $1.47M | EDGAR |
| 2020-09-11 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +21,000 | $589.7K | EDGAR |
| 2020-07-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +613 | $15.7K | EDGAR |
| 2020-05-28 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +1,024 | $15.7K | EDGAR |